Zepbound KwikPen, a 4-dose single-patient delivery device for tirzepatide administration has been made available by Lilly.
Nutrition and lifestyle interventions, including whole-food plant-based diets, show promise in managing mood disorders and ...
Clinically significant fatigue affects half of individuals with MASLD and is linked to depression, anxiety, and ...
Steatotic liver disease is linked to greater frailty and lower muscle density compared with other liver disease etiologies.
Metabolic syndrome exacerbates inpatients outcomes and increased health care use among patients hospitalized with IBD.
The FDA proposed new guidelines for approving experimental therapies for rare diseases without large group studies.
Colorectal cancer was more common among patients with inflammatory bowel disease who had high-grade dysplasia.
In patients with type 2 diabetes and/or obesity with MASLD, advanced liver fibrosis is not associated with cardiovascular disease but is significantly linked to increased risk for HFpEF. Advanced ...
A reduced thyroid activity profile among individuals with MASLD is associated with an increased risk for both major liver and cardiovascular events. Higher thyroid-stimulating hormone (TSH) levels and ...
FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.
MASLD is present in over 70% of outpatients with type 2 diabetes. In addition, a 2-tier screening approach is useful for liver fibrosis stratification.
Statin use among individuals with cirrhosis is associated with a significantly reduced risk for hepatocellular carcinoma, hepatic decompensation, and all-cause mortality.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results